BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 13369451)

  • 1. [Severe hypoglycemic reactions during peroral treatment of diabetes with N1-sulfanilyl-n-2-n-butylcarbamid (BZ 55)].
    BENDFELDT E; OTTO H
    Munch Med Wochenschr; 1956 Aug; 98(35):1136-7. PubMed ID: 13369451
    [No Abstract]   [Full Text] [Related]  

  • 2. [Case of very severe allergic reaction in peroral management of diabetes mellitus with a sulfonyl urea derivative, N1-sulfanilyl-N2-n-butylcarbamide].
    FELLER J; KUPPER HJ
    Medizinische; 1956 Nov; 1(46):1641-5. PubMed ID: 13386742
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experiences with peroral administration of antidiabetic drug BZ-55 (invenol)].
    BRESGEN C
    Med Klin; 1956 Jul; 51(29):1224-7. PubMed ID: 13358484
    [No Abstract]   [Full Text] [Related]  

  • 4. [Introduction of new peroral hypoglycemic drugs for the ambulant treatment of diabetes mellitus].
    STRATMANN FW
    Medizinische; 1956 Sep; 24(36):1253-7. PubMed ID: 13377930
    [No Abstract]   [Full Text] [Related]  

  • 5. [N1-sulfanilyl-N2-n-butylcarbamide therapy of diabetes mellitus].
    DALLE COSTE P; KLINGER R
    Minerva Med; 1956 Sep; 47(76):735-43. PubMed ID: 13387177
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of ten cases of diabetes with oral hypoglycemic sulfonamide BZ 55 or nadisan].
    FERNANDEZ BASABE E; GALAN J; OLIVER A; OLIVER-PASCUAL E; PURAS E
    Rev Esp Enferm Apar Dig Nutr; 1956; 15(2):478-88. PubMed ID: 13370980
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of a hypoglycemic sulfonamide derivative (BZ 55) on the effectiveness of insulin in diabetics].
    BARTELHEIMER H; MARING H
    Klin Wochenschr; 1956 Oct; 34(37-38):1011-6. PubMed ID: 13377627
    [No Abstract]   [Full Text] [Related]  

  • 8. [The antidiabetic action of BZ 55 in clinical experience].
    BELTRAMETTI L; ZAMPORI O
    G Clin Med; 1956 Sep; 37(9):1249-64. PubMed ID: 13384741
    [No Abstract]   [Full Text] [Related]  

  • 9. [BZ 55 of D 860 as oral antidiabetic].
    MEHNERT B; MEHNERT H
    Munch Med Wochenschr; 1956 Sep; 98(39):1325-8. PubMed ID: 13378442
    [No Abstract]   [Full Text] [Related]  

  • 10. [Examination of steroids in therapy with N'-sulfanilyl-N2-N-butylcarbamid (nadisan)].
    RAUSCH-STROOMANN JG; SAUER H
    Klin Wochenschr; 1956 Jul; 34(25-26):707-8. PubMed ID: 13347046
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of diabetes mellitus with hypoglycemic sulfonamides].
    BOULIN R
    Gaz Med Fr; 1957 Mar; 64(6):545-53. PubMed ID: 13427960
    [No Abstract]   [Full Text] [Related]  

  • 12. [Management of diabetes with a peroral sulfonamide derivative, BZ 55; preliminary experience].
    AARSETH S
    Tidsskr Nor Laegeforen; 1956 Sep; 76(18):641-6. PubMed ID: 13380825
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences in diabetes therapy with hypoglycemic sulfonamide compounds].
    BREDNOW W; JORKE D
    Munch Med Wochenschr; 1957 Jan; 99(4):101-5. PubMed ID: 13407645
    [No Abstract]   [Full Text] [Related]  

  • 14. CURRENT investigation of the hypoglycemic action of sulfonylureas.
    Nutr Rev; 1957 May; 15(5):150-1. PubMed ID: 13431090
    [No Abstract]   [Full Text] [Related]  

  • 15. [Findings in the course of antidiabetic treatment with 1-para-aminobenzenesulfonyl-3-N-butyl urea].
    MORSIANI M; SERRAVALLI S
    Arcisp S Anna Ferrara; 1956; 9(4):747-59. PubMed ID: 13382613
    [No Abstract]   [Full Text] [Related]  

  • 16. [Liver function in diabetics treated with N-sulfanilyl-N'-butyl urea].
    DI NOIA V; GALLETTI F; PELLEGRINI R
    Minerva Med; 1956 Sep; 47(73):613-4. PubMed ID: 13387155
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypoglycemic effect of new sulfonamide N1-sulfanilyl-N2-n-butyl-carbamide (Bz 55) in surgical patients].
    CORTINOVIS R
    Riforma Med; 1956 Jul; 70(27):764-7. PubMed ID: 13351284
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypoglycaemic sulphonamides in the management of diabetes mellitus.
    DOWNIE E; BORNSTEIN J; HUDSON B
    Australas Ann Med; 1957 May; 6(2):105-12. PubMed ID: 13445634
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of the peroral antidiabetic drug, N1-sulfanilyl-N'-butyl urea (nadisan, invenol) on diabetes mellitus in man].
    KLOTZBUCHER E
    Z Gesamte Inn Med; 1956 Dec; 11(23):1075-81. PubMed ID: 13423436
    [No Abstract]   [Full Text] [Related]  

  • 20. [Oral treatment of diabetes mellitus with D-860, a new hypoglycemic but not sulfonamidic drug; clinical study of 90 cases].
    INTROZZI P; MARIGO S
    Prog Med (Napoli); 1956 Sep; 12(17):513-27. PubMed ID: 13379550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.